| Name | Title | Type |
|---|---|---|
| Kathleen Broadhurst | Sr. Director of Finance | Auditee |
| Kari Young | Partner/Shareholder | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 324276 | 2024 | 2024-10-09 | Jones & Roth PC | $1.16M |
| 295334 | 2023 | 2024-03-15 | Jones & Roth PC | $1.17M |
| 47500 | 2022 | 2023-03-23 | Jones & Roth PC | $1.16M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 324276 | 2024 | 2024-10-09 | 1078533 | 2024-004 | Significant Deficiency | Yes | I |
| 324276 | 2024 | 2024-10-09 | 1078532 | 2024-003 | Significant Deficiency | Yes | L |
| 324276 | 2024 | 2024-10-09 | 1078531 | 2024-002 | Material Weakness | Yes | E |
| 324276 | 2024 | 2024-10-09 | 502091 | 2024-004 | Significant Deficiency | Yes | I |
| 324276 | 2024 | 2024-10-09 | 502090 | 2024-003 | Significant Deficiency | Yes | L |
| 324276 | 2024 | 2024-10-09 | 502089 | 2024-002 | Material Weakness | Yes | E |
| 295334 | 2023 | 2024-03-15 | 956991 | 2023-003 | Significant Deficiency | Yes | I |
| 295334 | 2023 | 2024-03-15 | 956990 | 2023-002 | Significant Deficiency | - | L |
| 295334 | 2023 | 2024-03-15 | 956989 | 2023-001 | Material Weakness | Yes | E |
| 295334 | 2023 | 2024-03-15 | 380549 | 2023-003 | Significant Deficiency | Yes | I |
| 295334 | 2023 | 2024-03-15 | 380548 | 2023-002 | Significant Deficiency | - | L |
| 295334 | 2023 | 2024-03-15 | 380547 | 2023-001 | Material Weakness | Yes | E |
| 47500 | 2022 | 2023-03-23 | 620077 | 2022-004 | Material Weakness | - | E |
| 47500 | 2022 | 2023-03-23 | 620076 | 2022-003 | Significant Deficiency | Yes | I |
| 47500 | 2022 | 2023-03-23 | 620075 | 2022-002 | Significant Deficiency | Yes | N |
| 47500 | 2022 | 2023-03-23 | 43635 | 2022-004 | Material Weakness | - | E |
| 47500 | 2022 | 2023-03-23 | 43634 | 2022-003 | Significant Deficiency | Yes | I |
| 47500 | 2022 | 2023-03-23 | 43633 | 2022-002 | Significant Deficiency | Yes | N |